Publications

The anti-obesity drug revolution: a booming market

Article published in allnews on October 4, 2024

“Innovation is the key to success for pharmaceutical companies, whose leadership position can waver at any moment.”

At a time when obesity has become a global priority, pharmaceutical companies are racing to develop innovative solutions. Leaders such as Eli Lilly and Novo Nordisk currently dominate, but competition is intensifying and new molecules could change the game.

Read the commentary by Stéphanie Rheinboldt, Senior Equity Advisor, published in Allnews on October 4, 2024, in French : La course aux médicaments anti-obésité | Allnews

October 04, 2024

Publications

Washington Shifts, Fundamentals Hold

The new political landscape in Washington adds uncertainty, particularly around fiscal policy and Treasury financing needs. However, solid earnings and broadly resilient growth continue to support our central scenario.

November 10, 2026

Publications

Banque Heritage CEO: “I’m too young to retire"

Geneva-based Banque Heritage is pursuing ambitious growth plans, including a potential expansion into the external asset management business.

November 09, 2026

Publications

Digital sovereignty is a fundamental trend

In Swissquote Magazine’s feature on European digital sovereignty, Eunice Harbeke, Investment Advisor at Banque Heritage, shares her view on this investment theme.

November 03, 2026